One in three adults aged 60 and over suffering from a hip fracture dies within one year. Now, a Purdue University-affiliated startup is moving closer to the start of clinical trials for a novel injectable drug that is targeted to heal broken bones faster and strengthen weak bones.

InquireFirst is pleased to announce a new initiative to encourage cross-border reporting on science, health and the environment by Latin American journalists.

Bayer and Meiogenix, a biotech company focused on next-generation breeding technologies, announced today a collaboration to advance agricultural research and development by accelerating the development of Meiogenix’s proprietary technologies related to plant breeding and genome editing applications. This new research collaboration has the potential to deliver much-needed plant health and nutrition improvements to food crops so farmers can more efficiently and sustainably grow improved plant varieties that deliver the types of foods consumers want.

In cancer research, electrospun synthetic cell scaffolds hold the potential to replace animal testing as they are more consistent than animal cells.

CRISPR Brought Under GMO Rules By French Administrative Court

Influenza B Protein Structure – MIT Chemists Reveal the Protein Structure

Light Chain Bioscience, a unit of Swiss biotech Novimmune, has been handed a nice royalty milestone check from partner Takeda Pharmaceutical.

A U.S. bankruptcy court has given groups interested in buying antibiotic biotech Melinta Therapeutics until March 2 to make an offer. The bidding process creates an opportunity for Melinta’s business to continue as a going concern despite its financial difficulties.

CICC Capital has raised a RMB 1.6 billion ($229 million) biologic investment fund. The fund received money from Chinese organizations inside and outside the biopharma industry, enabling CICC Capital to ease past its financing target.

In its fourth-quarter earnings out early Friday morning, U.K.-based Big Pharma AstraZeneca has cut two early-stage experimental meds.